WO1998057992A3 - Antikörper gegen flip-protein - Google Patents

Antikörper gegen flip-protein Download PDF

Info

Publication number
WO1998057992A3
WO1998057992A3 PCT/EP1998/003641 EP9803641W WO9857992A3 WO 1998057992 A3 WO1998057992 A3 WO 1998057992A3 EP 9803641 W EP9803641 W EP 9803641W WO 9857992 A3 WO9857992 A3 WO 9857992A3
Authority
WO
WIPO (PCT)
Prior art keywords
flip protein
antibodies
relates
protein antibodies
expression vectors
Prior art date
Application number
PCT/EP1998/003641
Other languages
English (en)
French (fr)
Other versions
WO1998057992A2 (de
Inventor
Juerg Tschopp
Margot Thome
Kimberly Burns
Martin Irmler
Michael Hahne
Michael Schroeter
Pascal Schneider
Jean-Luc Bodmer
Veronique Steiner
Donata Rimoldi
Kay Hoffmann
E Lars French
Original Assignee
Apotech Sa
Juerg Tschopp
Margot Thome
Kimberly Burns
Martin Irmler
Michael Hahne
Michael Schroeter
Pascal Schneider
Bodmer Jean Luc
Veronique Steiner
Donata Rimoldi
Kay Hoffmann
E Lars French
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apotech Sa, Juerg Tschopp, Margot Thome, Kimberly Burns, Martin Irmler, Michael Hahne, Michael Schroeter, Pascal Schneider, Bodmer Jean Luc, Veronique Steiner, Donata Rimoldi, Kay Hoffmann, E Lars French filed Critical Apotech Sa
Priority to AU87996/98A priority Critical patent/AU8799698A/en
Publication of WO1998057992A2 publication Critical patent/WO1998057992A2/de
Publication of WO1998057992A3 publication Critical patent/WO1998057992A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Die Erfindung betrifft Antikörper, die gegen Epitope von FLIP-Proteinen gerichtet sind, darüber hinaus solche DNA-Sequenzen, die für Antikörper kodieren, die gegen Epitope von FLIP-Proteinen gerichtet sind, außerdem Expressionsvektoren mit den oben genannten DNA-Sequenzen und Wirtszellen, die mit diesen Expressionsvektoren transformiert sind, wobei die Erfindung mit Hilfe der verschiedenen Erfindungsgegenstände in die Regulation des programmierten Zelltods eingreift.
PCT/EP1998/003641 1997-06-18 1998-06-17 Antikörper gegen flip-protein WO1998057992A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU87996/98A AU8799698A (en) 1997-06-18 1998-06-17 Anti-flip protein antibodies

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1997125847 DE19725847A1 (de) 1997-06-18 1997-06-18 Antikörper gegen FLIP-Protein
DE19725847.6 1997-06-18

Publications (2)

Publication Number Publication Date
WO1998057992A2 WO1998057992A2 (de) 1998-12-23
WO1998057992A3 true WO1998057992A3 (de) 1999-03-18

Family

ID=7832899

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/003641 WO1998057992A2 (de) 1997-06-18 1998-06-17 Antikörper gegen flip-protein

Country Status (3)

Country Link
AU (1) AU8799698A (de)
DE (1) DE19725847A1 (de)
WO (1) WO1998057992A2 (de)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
J. BERTIN ET AL.: "Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE U.S.A., vol. 94, no. 4, 18 February 1997 (1997-02-18), Washington, DC, USA, pages 1172 - 1176, XP002089676 *
M. IRMLER ET AL.: "Inhibition of death receptor signals by cellular FLIP.", NATURE, vol. 388, no. 6638, 10 July 1997 (1997-07-10), London, GB, pages 190 - 195, XP002089677 *
M. THOME ET AL.: "Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors.", NATURE, vol. 386, no. 6624, 3 April 1997 (1997-04-03), London, GB, pages 517 - 521, XP002089675 *

Also Published As

Publication number Publication date
AU8799698A (en) 1999-01-04
WO1998057992A2 (de) 1998-12-23
DE19725847A1 (de) 1998-12-24

Similar Documents

Publication Publication Date Title
WO2001004264A3 (en) Atherosclerosis-associated genes
WO2004101760A3 (en) Novel lipolytic enzyme elip
WO2000012726A3 (en) Rationally designed heparinases derived from heparinase i and ii
WO2000061622A3 (en) Genes associated with diseases of the kidney
WO2002062999A3 (en) Proteins and nucleic acids encoding same
WO2002046409A3 (en) Proteins and nucleic acids encoding same
WO2002059315A3 (en) Human nucleic acids and polypeptides and methods of use thereof
WO1995027059A1 (en) Afamin: a human serum albumin-like protein
WO2002081517A3 (en) Novel polypeptides and nucleic acids encoded thereby
WO1999067384A3 (en) Prostate cancer-associated genes
WO2001012660A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
CA2361987A1 (en) Goodpasture antigen binding protein
WO2001002563A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
WO2003062453A3 (en) Polycystic kidney disease nucleic acids and proteins
WO1998055509A3 (en) Two human dnaj-like proteins
WO2002085922A3 (en) Proteins and nucleic acids encoding same
WO2000021986A3 (en) Matrix-remodeling genes
WO2000059942A3 (en) Human obesity protein binding protrein-2 homolog and uses thereof
WO2000040722A3 (en) Insulin-synthesis genes
WO1998057992A3 (de) Antikörper gegen flip-protein
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO2002090500A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO1999057277A3 (en) Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
WO2002046408A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2000070036A3 (en) Genes expressed in hippocampus

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AU BA BB BG BR CA CN CU CZ EE GE GW HU ID IL IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK SL TR TT UA US UZ VN YU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AU BA BB BG BR CA CN CU CZ EE GE GW HU ID IL IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK SL TR TT UA GH

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1999503736

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase